-
N159746-100gSelective COX-2 NSAID.
-
N159746-1gSelective COX-2 NSAID.
-
N159746-25gSelective COX-2 NSAID.
-
N159746-5gSelective COX-2 NSAID.
-
N104910-1gSubstrate for dehydrogenases and other oxidases.
-
N104910-250mgSubstrate for dehydrogenases and other oxidases.
-
N104910-25gSubstrate for dehydrogenases and other oxidases.
-
N104910-50mgSubstrate for dehydrogenases and other oxidases.
-
N104910-5gSubstrate for dehydrogenases and other oxidases.
-
N127928-100mgNVP-BHG712 is a specific EphB4 inhibitor with ED50 of 25 nM that discriminates between VEGFR and EphB4 inhibition: also shows activity against c-Raf, c-Src and c-Abl with IC50 of 0.395 μM, 1.266 μM and 1.667 μM, respectively.
-
N127928-25mgNVP-BHG712 is a specific EphB4 inhibitor with ED50 of 25 nM that discriminates between VEGFR and EphB4 inhibition: also shows activity against c-Raf, c-Src and c-Abl with IC50 of 0.395 μM, 1.266 μM and 1.667 μM, respectively.
-
N127928-5mgNVP-BHG712 is a specific EphB4 inhibitor with ED50 of 25 nM that discriminates between VEGFR and EphB4 inhibition: also shows activity against c-Raf, c-Src and c-Abl with IC50 of 0.395 μM, 1.266 μM and 1.667 μM, respectively.